Skip to main content

Question for Department of Health and Social Care

UIN 132448, tabled on 14 March 2018

To ask the Secretary of State for Health and Social Care, what timeline is for NHS England to complete commercial negotiations with pharmaceutical companies after a treatment has met the NICE budget impact test; and what steps he is taking to ensure that those treatments are available to patients in a timely manner.

Answered on

19 March 2018

The timescales for the commercial negotiations for products that trigger the budget impact test are set out in the ‘Procedure for varying the funding requirement to take account of net budget impact’ which is published at:

https://www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NICE-technology-appraisals/TA-HST-procedure-varying-the-funding-direction.pdf

The process has been designed to ensure that, wherever possible, the commercial negotiation takes place in parallel with the technology appraisal and does not affect patient access.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.